Physician profile
Jott C Hallman
NPI 1447389671
$1,991.52
in general payments reported to CMS, 2019-2025
24 companies · $559 in 2025
The $559 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $38.87 · 2021: $16.96 · 2022: $362 · 2023: $436 · 2024: $245 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $268.65 | 2022-2025 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $244.66 | 2025 | Upsylon, General - Female Sui |
| Sumitomo Pharma America, INC. | $213.68 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $184.43 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $146.98 | 2022-2025 | |
| Intuitive Surgical, INC. | $115.06 | 2023 | Da Vinci Surgical System |
| Organon LLC | $81.33 | 2022-2025 | Jada System |
| Daiichi Sankyo INC. | $72.66 | 2019-2024 | Injectafer |
| Urovant Sciences INC | $70.43 | 2022 | |
| Exeltis, USA INC. | $65.19 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $60.69 | 2019-2025 | |
| Aspira Women'S Health INC | $58.77 | 2022 | |
| Avion Pharmaceuticals | $55.70 | 2019 | |
| Axonics, INC. | $54.03 | 2024 | Axonics, Bulkamid |
| Therapeuticsmd, INC. | $53.29 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $48.64 | 2022 | |
| Allergan, INC. | $41.42 | 2019 | |
| Amgen INC. | $38.95 | 2019 | |
| Pfizer INC. | $29.83 | 2025 | |
| Lupin INC. | $23.22 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $21.97 | 2019 | |
| Novo Nordisk INC | $16.23 | 2023 | Wegovy |
| Exact Sciences Corporation | $14.30 | 2025 | The Cologuard Plus Collection Kit |
| Amag Pharmaceuticals, INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jott Hallman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.